Osteoporosis during androgen deprivation therapy for prostate cancer.
Published Sep 1, 2002 · Matthew R. Smith
Urology
95
Citations
3
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeawayOsteoporosis during androgen deprivation therapy for prostate cancer can be managed through lifestyle modification, supplementation, and alternative hormonal therapy.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.